271 related articles for article (PubMed ID: 32677996)
41. A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.
Ho J; Grabowska A; Ugarte M; Muqit MM
Eye (Lond); 2018 Sep; 32(9):1449-1454. PubMed ID: 29786087
[TBL] [Abstract][Full Text] [Related]
42. Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.
Lee JY; Jeong HS; Lee DY; Sohn HJ; Nam DH
Retina; 2012 Oct; 32(9):1767-74. PubMed ID: 22481480
[TBL] [Abstract][Full Text] [Related]
43. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
[TBL] [Abstract][Full Text] [Related]
44. Jamming of 25-gauge instruments in the cannula during vitrectomy for vitreous haemorrhage.
Shinoda H; Nakajima T; Shinoda K; Suzuki K; Ishida S; Inoue M
Acta Ophthalmol; 2008 Mar; 86(2):160-4. PubMed ID: 17908259
[TBL] [Abstract][Full Text] [Related]
45. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
46. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.
Yeh PT; Yang CM; Yang CH; Huang JS
Ophthalmology; 2005 Dec; 112(12):2095-102. PubMed ID: 16225926
[TBL] [Abstract][Full Text] [Related]
47. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
[TBL] [Abstract][Full Text] [Related]
48. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.
West JF; Gregor ZJ
Br J Ophthalmol; 2000 Aug; 84(8):822-5. PubMed ID: 10906084
[TBL] [Abstract][Full Text] [Related]
49. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents.
Fabinyi DC; O'Neill EC; Connell PP; Clark JB
Clin Exp Ophthalmol; 2011 Dec; 39(9):878-84. PubMed ID: 21631675
[TBL] [Abstract][Full Text] [Related]
50. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
51. POSTERIOR VITREOUS DETACHMENT STATUS AS A PREDICTIVE FACTOR FOR OUTCOMES OF VITRECTOMY FOR DIABETIC VITREOUS HEMORRHAGE.
Tandias R; Lemire CA; Palvadi K; Arroyo JG
Retina; 2022 Jun; 42(6):1103-1110. PubMed ID: 35594076
[TBL] [Abstract][Full Text] [Related]
52. Pars plana vitrectomy: comparison of three techniques for the treatment of diabetic vitreous hemorrhage.
Bahar I; Axer-Siegel R; Weinberger D
Ophthalmic Surg Lasers Imaging; 2006; 37(5):364-9. PubMed ID: 17017195
[TBL] [Abstract][Full Text] [Related]
53. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Sonoda KH; Sakamoto T; Enaida H; Miyazaki M; Noda Y; Nakamura T; Ueno A; Yokoyama M; Kubota T; Ishibashi T
Ophthalmology; 2004 Feb; 111(2):226-30. PubMed ID: 15019367
[TBL] [Abstract][Full Text] [Related]
54. Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy.
Song A; Ghareeb A; Mehta A; Sadiq SN; Al-Zubaidy M; Murphy DC; Mostafa I; Tzoumas N; Steel DHW
Eye (Lond); 2022 Jan; 36(1):8-9. PubMed ID: 34040188
[No Abstract] [Full Text] [Related]
55. 25-Gauge transconjunctival sutureless pars plana vitrectomy.
Yanyali A; Celik E; Horozoglu F; Oner S; Nohutcu AF
Eur J Ophthalmol; 2006; 16(1):141-7. PubMed ID: 16496259
[TBL] [Abstract][Full Text] [Related]
56. Long-term visual and retinopathy outcomes in a predominately type 2 diabetic patient population undergoing early vitrectomy and endolaser for severe vitreous haemorrhage.
Ratnarajan G; Mellington F; Saldanha M; de Silva SR; Benjamin L
Eye (Lond); 2011 Jun; 25(6):704-8; quiz 709. PubMed ID: 21494282
[TBL] [Abstract][Full Text] [Related]
57. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.
Lövestam-Adrian M; Agardh CD; Torffvit O; Agardh E
Acta Ophthalmol Scand; 2003 Jun; 81(3):221-5. PubMed ID: 12780397
[TBL] [Abstract][Full Text] [Related]
58. Visual outcome of 25-gauge microincision vitrectomy surgery in diabetic vitreous haemorrhage.
Khan BA; Rizvi SF; Mahmood SA; Mal W; Zafar S
Pak J Med Sci; 2015; 31(5):1197-200. PubMed ID: 26649013
[TBL] [Abstract][Full Text] [Related]
59. Experimental model to evaluate mechanical closure resistance of sutureless vitrectomy sclerotomies using pig eyes.
Lopez-Guajardo L; Benitez-Herreros J; Silva-Mato A
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4080-4. PubMed ID: 21436274
[TBL] [Abstract][Full Text] [Related]
60. Visual outcomes and prognostic factors following 23G vitrectomy for vitreous hemorrhage in eyes with proliferative diabetic retinopathy.
Damian I; Nicoară SD
Arq Bras Oftalmol; 2023; 86(2):105-112. PubMed ID: 35319648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
